Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Axsome Therapeutics revenue
Axsome Therapeutics's revenue is $385.7 million.
What is Axsome Therapeutics's revenue?
- Axsome Therapeutics's revenue growth from 2022 to 2024 is 670.82%.
- Axsome Therapeutics has 29 employees, and the revenue per employee ratio is $13,299,758.
- Axsome Therapeutics's peak quarterly revenue was $118.8M in 2024(q4).
- Axsome Therapeutics peak revenue was $385.7M in 2024.
- Axsome Therapeutics annual revenue for 2023 was 270.6M, 440.8% growth from 2022.
- Axsome Therapeutics annual revenue for 2024 was 385.7M, 42.53% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Axsome Therapeutics historical revenue
Axsome Therapeutics annual revenue
Axsome Therapeutics annual revenue over time
| Fiscal year / year | Axsome Therapeutics revenue |
|---|---|
| 2022 | $50.0M |
| 2023 | $270.6M |
| 2024 | $385.7M |
Axsome Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Axsome Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2022 | - | $8.8M | $16.8M | $24.4M |
| 2023 | $94.6M | $46.7M | $57.8M | $71.5M |
| 2024 | $75.0M | $87.2M | $104.8M | $118.8M |
Axsome Therapeutics jobs nearby
Do you work at Axsome Therapeutics?
Is Axsome Therapeutics transparent about its revenue structure?
Axsome Therapeutics financial information
| CEO | Herriott Tabuteau |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 29 |
| Date Founded | 2012 |
| Headquarters | New York, New York |
| Number of Locations | 1 |
| Revenue | $385.7M |
| Net Income | -$187,133,651 |
| Gross Proft | $352.4M (2024) |
| EBITDA | ($274.2M) (2024) |
| Tax Rate | -0.0% |
| Total Assets | $331,476,000 |
| Ticker | AXSM |
Axsome Therapeutics jobs you might like
Axsome Therapeutics financing
Axsome Therapeutics received early financing of $1.2M on 2013-07-03.
| Series | Round size | Date |
|---|---|---|
| Debt Financing | $1.2M | 07/2013 |
| Debt Financing | $2M | 09/2014 |
| Debt Financing | $1.3M | 01/2015 |
| Series Unknown | $2.5M | 05/2015 |
| Post Ipo Equity | $200M | 12/2019 |
Axsome Therapeutics competitors
Axsome Therapeutics's top competitor, OPKO Health, earned an annual revenue of $713.1M.
Axsome Therapeutics's smallest competitor is Relmada Therapeutics with revenue of $5.1K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| VistaGen Therapeutics | - | $1.1M | 18 | - |
| Omeros | - | $29.9M | 265 | - |
| MediciNova | - | $1.0M | 13 | - |
| Sage Therapeutics | - | $41.2M | 637 | - |
| Genprex | - | $45.0M | 7 | - |
| Axial Therapeutics | - | $350,000 | 30 | - |
| Onconova Therapeutics | - | $226,000 | 12 | - |
| Intra-Cellular Therapies | - | $680.9M | 73 | - |
| KemPharm | - | $23.6M | 22 | - |
| Aclaris Therapeutics | - | $18.7M | 60 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Axsome Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Axsome Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Axsome Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Axsome Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Axsome Therapeutics. The data presented on this page does not represent the view of Axsome Therapeutics and its employees or that of Zippia.
Axsome Therapeutics may also be known as or be related to AXSOME THERAPEUTICS INC., Axsome Therapeutics, Axsome Therapeutics Inc, Axsome Therapeutics Inc. and Axsome Therapeutics, Inc.